MYC and myeloid leukemia: In vitro studies, we found that matrine can specifically target c-Myc in myeloid leukemia cells, and matrine exerts its anti-leukemic effect by inhibiting c-Myc, but these conclusions have not yet been tested in vivo, which is also a pity of this study.